|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2023―Dec―04 |
Analysis of SARS-CoV-2 Variant-Specific Serum Antibody Post-Vaccination Utilizing Immortalized Human Hepatocyte-Like Cells (HLC) to Assess Development of Immunity |
Daniel Collins, Clifford Steer |
2 |
[GO] |
2023―Nov―06 |
COVID-19 and the Liver: A Complex and Evolving Picture |
Simon Taylor-Robinson, Marsha Morgan |
3 |
[GO] |
2023―Oct―04 |
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention |
Joseph K Lim, Basile Njei |
4 |
[GO] |
2023―Sep―29 |
The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era |
Richie Manikat, Aijaz Ahmed, Donghee Kim |
5 |
[GO] |
2023―Aug―01 |
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients? |
Alessandra Bartoli, Carmela Cursaro, Hajrie Seferi, Pietro Andreone |
6 |
[GO] |
2023―Feb―21 |
COVID-19-Associated Liver Injury |
Daniel T Gildea, Stephanie M Woo, Corinne E O'Connor, Amol S Rangnekar |
7 |
[GO] |
2021―Apr―13 |
Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis |
Daniel P Collins, Clifford J Steer |